Keywords: USA, FDA, Pfizer, Lyrica, GAD, The Medicines Company, ApoA-I Milano

US FDA calls for more data on Pfizer's Lyrica for generalized anxiety disorder; sells drug rights to TMC

Article | 24 December 2009

Print This

The US Food and Drug Administration has issued a Complete Response letter regarding global drugs behemoth Pfizer’s New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in